INTERBRI · CHINA MARKET ACCESS FOR MEDICAL DEVICES China-focused support. Clear scope. Accountable coordination.
Regulatory Analysis

China FDA vs NMPA: Finding the Official Regulator for Medical Devices

9 min readRegulator & official portals

If you have been asked to find the “China FDA website”, you are not alone. The phrase is common in English-language regulatory work, but it does not match the name of any current Chinese authority. Medical devices in China are regulated by the National Medical Products Administration (NMPA). This guide sets out which official portals to use, how responsibilities are divided, and why getting the authority right matters when you appoint an agent and prepare a submission.

1. The short answer: there is no agency called “China FDA”

Chinese rules assign medical device oversight to the drug regulatory department under the State Council — today the NMPA. English-language materials sometimes say “China FDA”, “CFDA” or “SFDA”. Those labels appear in older documents and on older third-party pages; they are not the current authority’s name. The NMPA’s own English site identifies the agency as the National Medical Products Administration, and the current registration rules name the NMPA as the body administering registration and filing nationwide.

The practical consequence is small but real. When a form, an agency agreement or a certificate names the authority, use the current official name and check it against the regulator’s own site. A document built around a superseded agency name is not automatically invalid — but it is a warning sign that the template behind it may also be out of date.

Identify the authority by what the current official text says, not by how a third-party page labels it. Titles vary in translation; the decree number does not.

2. Who does what in China’s device regulatory system

The division of work is described in the official English text of the Provisions for Medical Device Registration and Filing (SAMR Decree No. 47), the departmental rule implementing the State Council’s Regulations on the Supervision and Administration of Medical Devices (State Council Decree No. 739). Three layers matter to an overseas manufacturer.

2.1 The NMPA — national regulator

The NMPA administers registration and filing nationwide, establishes the registration system, and supervises the work of local drug regulatory departments. For imported products this is the decisive point: filings for imported Class I devices and the review and approval of imported Class II and Class III devices are handled at national level, not by a provincial office. The authority also publishes registration and filing information.

2.2 CMDE and the technical institutions

Technical evaluation of registration, change and renewal applications for domestic Class III and imported Class II and Class III devices is carried out by the Center for Medical Device Evaluation of the NMPA (CMDE). Other NMPA institutions cover standards, classification definition, testing, inspection, monitoring and re-evaluation, and certificate production. In practice a submission moves between an administrative receiving function and a technical review function — both sit inside the same regulatory system, and both are reached through your appointed agent.

2.3 Provincial and municipal authorities

Provincial drug regulatory departments handle domestic Class II registration and quality management system inspections; municipal departments handle domestic Class I filings. These routes matter mainly for devices manufactured in China. An overseas manufacturer exporting into China generally deals with the national level instead — one of the reasons the “which website” question is worth settling early.

3. The official websites worth bookmarking

Table: 3. The official websites worth bookmarking
What you needOfficial portalWhat it is for
Current laws, announcements and guidance (Chinese originals)NMPA websiteThe primary source. Chinese text is the authoritative version.
English laws, announcements and regulatory informationNMPA English siteOfficial English texts, including the registration rules and classification rules.
Legal status and downloadable PDFsSAMR laws & regulations databaseShows whether a text is currently effective and offers text/PDF download.
Registration and filing outcomesNMPA websitePublic registration and filing information published by the authority.

Only regulator-operated sites can answer a regulatory question authoritatively. A commercial page that ranks well for “China FDA website” is not a regulator and cannot confirm whether a product is approved.

4. Why the naming question matters to an overseas manufacturer

  • Your China legal agent is the channel to the NMPA. SAMR Decree No. 47 requires overseas applicants and filers to appoint an enterprise legal person in China as their agent to handle registration and filing matters. See China Medical Device Agent services.
  • The receiving authority depends on class and origin. Imported Class I devices are filed with the NMPA; imported Class II and Class III devices are reviewed by the NMPA for registration. Confirm the class before any paperwork begins — see China medical device classification.
  • Legacy English documents can describe a different process. When Decree No. 47 took effect, the NMPA announced that a list of earlier registration management documents was abolished at the same time. Older CFDA-era templates may not reflect the current submission route.
  • Verification belongs on the official portal. Registration and filing results are published by the authority; treat any private “certificate lookup” as a convenience, not as evidence.
If a supplier, distributor or service provider cannot tell you which official text a requirement comes from, treat the requirement as unconfirmed until you have checked it yourself.

5. A five-step verification routine

  • Confirm the current authority name on the NMPA’s own site rather than on a third-party page.
  • Identify the controlling text by its Chinese title and decree number — English translations of Chinese legal titles vary between publishers.
  • Check the text’s effectiveness status in the official SAMR database before relying on it.
  • Check for implementing announcements, classification catalogues and technical guidelines that affect how the rule is applied.
  • Record the source, the version and the date you checked it in your regulatory file.

For a fuller walk-through of the source hierarchy, English translations and where to obtain official PDFs, see China medical device regulations: official sources and PDFs.

Frequently asked questions

QIs there an official “China FDA” website?

There is no current Chinese agency under that name. Medical devices are regulated by the National Medical Products Administration (NMPA), which operates a Chinese site and an official English site. Older documents may use CFDA or SFDA; those are earlier names, not a separate authority to contact today.

QWhich authority approves imported Class II and Class III medical devices?

Under SAMR Decree No. 47, imported Class II and Class III devices are reviewed by the NMPA, which issues the medical device registration certificate on approval. Imported Class I devices are filed with the NMPA rather than registered. Domestic products follow different, partly provincial routes.

QAre English-language versions of NMPA regulations authoritative?

The NMPA publishes official English texts for a number of rules on its English site, and these are valuable working references. For a submission, we treat the Chinese original published by the authority as the controlling text and confirm any requirement against the current Chinese version and applicable guidance.

QDo we need a local entity in China to file an application?

Yes. SAMR Decree No. 47 requires overseas applicants and filers to appoint an enterprise legal person in China as their agent to handle registration and filing matters. That regulatory role is distinct from a commercial distributor. See our China legal agent service and the explainer on the agent’s duties.

QWhere can we check whether a device is registered in China?

The drug regulatory departments publish registration and filing information, and the NMPA site is the place to start for imported products. For your own projects, keep the official publication record alongside your certificate rather than relying on a commercial database.

Official sources

The following links point to regulator or government-operated sites. Chinese originals are the authoritative texts; English materials are working references. Check the current version before relying on any document in a submission.

Working with INTERBRI

INTERBRI supports overseas manufacturers with China medical device registration, filing and China legal agent services. If you are unsure which authority, class or submission route applies to your product, we can review your product documentation together and set out the questions that need to be settled before a submission is planned. Requirements depend on classification, intended use and registration pathway and should be confirmed against the current official text for each individual product.

Discuss your product

Back to the Regulation Library